IFR US ECM Calendar
Week of February 23: AGT Food and Ingredients (Canada, food) ─ C$460m TSX IPO (Primary, Secondary). 15.33m-17.69m shares at C$26-$30. NBF, SCOT. TSX “AGTF”. OMERS is the selling shareholder.
February 24: Bicara Therapeutics (US, biotech) ─ $150m ABB. Fixed size (Primary) marketed at $16.00 fixed price versus $16.24 last sale. MS, TDC, BOFA, CANT, STFL. Wall cross.
February 24: Tandem Diabetes Care (US, medical devices) ─ $200m 6y cvt marketed at 0%, up 30%-35%. GS, BARC. Capped call.
February 24: Whirlpool (US, household appliances) ─ $400m FO. Fixed size (Primary) versus $83.21 at launch. WF, CITI, JPM, MIZU, BNPP. Concurrent $400m mandatory CB.
February 24: Whirlpool (US, household appliances) ─ $400m 3y mand cvt marketed at 8.25%-8.5% div, up 17.5%-22.5%. WF, CITI, JPM, MIZU, BNPP. Concurrent $400m common offering.
February 24: Zura Bio (US, biotech) ─ $100m ABB. Fixed size (Primary) marketed at $6.00-$6.25 versus $6.69 last sale. LEER, PS, CANT. Wall cross.
February 25: Palvella Therapeutics (US, biotech) ─ $150m FO. Fixed size (Primary) versus $120.41 at launch. TDC, CANT, STFL, MIZU, LSCI, OPCO, CGEN, HCW. Reverse inquiry.
February 25: Vir Biotechnology (US, biotech) ─ $200m FO. Fixed size (Primary) versus $9.49 at launch. GS, LEER, GUGG, BARC.
February 26: Generate Biomedicines (US, biotech) ─ $425m IPO. 25m shares (Primary) at $15-$17. GS, MS, PS, GUGG, CANT. Nasdaq “GENB”.
March 5: MiniMed (US, medical devices) ─ $784m IPO. 28m shares (Primary) at $25-$28. GS, BOFA, CITI, MS. Nasdaq “MMED”. Spin-off from Medtronic.
March 5: Robinhood Ventures Fund I (US, closed end fund) ─ $1bn IPO. 40m shares (Primary, Secondary) at $25.00. GS. Robinhood Markets is selling 5m shares. Marketing extended from scheduled 2/25 pricing.